Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated DNA Technologies (IDT) is a global leader in the manufacturing of custom nucleic acid products, serving the academic research, biotechnology, and pharmaceutical sectors. The company specializes in the synthesis of high-quality DNA and RNA oligonucleotides, which are critical components for molecular biology applications including PCR, gene sequencing, and CRISPR genome editing. IDT also offers a comprehensive suite of tools for functional genomics, synthetic biology, and molecular diagnostics. Following its acquisition by Danaher Corporation in 2018, IDT operates as a standalone entity within Danaher's Life Sciences segment, continuing to drive innovation in genomic research tools and providing essential reagents for researchers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Defense Technologies.